Breaking News
Get 40% Off 0
⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early. Unlock Stocks
Close

Jpmorgan Funds - Thematics - Genetic Therapies A (acc) - Usd (0P0001INWK)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
96.480 -0.860    -0.88%
28/05 - Delayed Data. Currency in USD ( Disclaimer )
  • Morningstar Rating:
  • Total Assets: 602.68M
Type:  Fund
Market:  Luxembourg
Issuer:  JPMorgan Asset Management (Europe) S.à r.l.
ISIN:  LU2050612402 
Asset Class:  Equity
JPMorgan Funds - Thematics - Genetic Therapies A ( 96.480 -0.860 -0.88%

0P0001INWK Holdings

 
Comprehensive information about top holdings and Key Holding Information for the JPMorgan Funds - Thematics - Genetic Therapies A ( (0P0001INWK) fund. Our JPMorgan Funds - Thematics - Genetic Therapies A ( portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 0.340 0.500 0.160
Stocks 99.660 99.660 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 19.874 19.037
Price to Book 2.993 4.009
Price to Sales 3.711 4.718
Price to Cash Flow 14.221 15.560
Dividend Yield 1.118 0.479
5 Years Earnings Growth 7.588 11.115

Sector Allocation

Name  Net % Category Average
Healthcare 100.000 99.753

Region Allocation

  • North America
  • Europe Developed
  • Asia
  • Australasia
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 106

Number of short holdings: 25

Name ISIN Weight % Last Change %
  Alnylam US02043Q1076 3.31 150.06 +1.56%
  Vertex US92532F1003 3.18 446.88 -2.20%
  Amgen US0311621009 3.12 300.19 -1.85%
  Novartis CH0012005267 3.08 90.84 -0.30%
  Biomarin Pharma US09061G1013 3.04 74.43 -1.44%
  Ionis Pharma US4622221004 3.02 37.64 +0.97%
  Gilead US3755581036 3.02 63.94 -2.65%
  Biogen US09062X1037 2.97 218.73 +0.42%
  Roche Holding Participation CH0012032048 2.96 230.50 +0.74%
  Crispr Therapeutics CH0334081137 2.91 54.84 -0.72%

Top Equity Funds by JPMorgan Asset Management (Europe) S.à r.l.

  Name Rating Total Assets YTD% 3Y% 10Y%
  Global Income Fund C div USD hedged 16.69B 0.62 2.00 4.30
  JPI Global Income Fund C dist USD h 16.69B 0.62 1.99 4.25
  JPI Global Income Fund A acc USD he 16.69B 0.77 0.22 3.48
  JPI Global Income Fund A div USD he 16.69B 0.78 0.24 3.49
  JPI Global Income Fund A mth USD he 16.69B 0.76 0.21 3.46
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0001INWK Comments

Write your thoughts about Jpmorgan Funds - Thematics - Genetic Therapies A (acc) - Usd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email